Author Question: A client is receiving medication for a hookworm infection. In planning education for the client, the ... (Read 60 times)

melly21297 · **on:** Jul 23, 2018

A client is receiving medication for a hookworm infection. In planning education for the client, the nurse knows it is essential to include which client-centered points?

Standard Text: Select all that apply.
1. Stop taking the medication when feeling better
2. Do not share doses with other family members with similar symptoms
3. Return to the health care provider if symptoms have not subsided after a full course of treatment
4. Report any fever that does not subside in 3 days
5. Report any increasing symptoms

Question 2

The nurse understands that a client with which condition might respond abnormally to primaquine therapy?

1. Diabetes insipidus
2. G-6-PD deficiency
3. Gout
4. Trisomy 13

Mholman93 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Correct Answer: 2,3,4,5
Rationale 1: The client should be instructed to complete the full course of medication even if symptoms subside.
Rationale 2: The client should be taught not to share doses of medication with other family members with similar symptoms.
Rationale 3: The client should be instructed to return of the health care provider if symptoms have not subsided after a full course of treatment.
Rationale 4: The client should be taught to report any fever that does not subside in 3 days of treatment.
Rationale 5: The client should be taught to report increasing symptoms to the health care provider.
Global Rationale: The client should be taught to take the full course of treatment, not to share medication with others, to report continued symptoms after a full course of treatment or if symptoms increase, and to report fever that does not subside.

Answer to Question 2

Correct Answer: 2
Rationale 1: Diabetes insipidus would not affect primaquine therapy.
Rationale 2: Clients with G-6-PD deficiency are at greater risk for hemolytic anemia.
Rationale 3: Gout is associated with uric acid and is not related to greater risk for primaquine therapy.
Rationale 4: Trisomy 13 is related to birth defects.
Global Rationale: Clients with G-6-PD deficiency are at greater risk for hemolytic anemia. The other conditions do not increase risk for adverse response.